On 26 Oct 2026, MEITUAN-W (03690.HK) proposed RMB senior notes to professional investors, with proceeds mainly to refinance offshore debt.
On 26 Oct 2026, BITFIRE GROUP (01611.HK) reported digital asset AUM of about US$221m, up 60.1% QoQ, and quarterly crypto trading volume of US$342m, up 362.2%.
On 26 Oct 2026, AKESO (09926.HK) said HARMONi-GI1 met its OS endpoint, with median OS of 14.9 vs 12.1 months in first-line biliary tract cancer.
On 26 Oct 2026, SHIMAO GROUP (00813.HK) said the 60-day period lapsed on 25 October, triggering defaults on offshore debt with about US$9.07bn outstanding.
On 26 Oct 2026, SHOUCHENG (00697.HK) said a managed fund invested in Beijing embodied-AI chip developer Huixi Intelligent; no amount was disclosed.
On 25 Oct 2026, REALORD TECH (01196.HK) said reports that its shares lost Stock Connect status were wrong; only the temporary 2922 counter was removed.
On 25 Oct 2026, SKB BIO (06990.HK) said sac-TMT data at ESMO showed PFS of 15.0 vs 5.7 months in first-line PD-L1-negative NSCLC.
On 25 Oct 2026, QUANTGROUP (02685.HK) said its unit will supply up to 2,000 AI guide robots to a Beijing car dealer by end-2027 under a non-binding framework.
On 25 Oct 2026, CSTONE PHARMA-B (02616.HK) reported CS2009 data in over 300 patients at ESMO, including 100% ORR in a 30 mg/kg first-line NSCLC cohort.
On 25 Oct 2026, LEADS BIOLABS-B (09887.HK) said LBL-034 data at ESMO showed median PFS of 21.8 months in 56 pretreated RRMM patients.
On 25 Oct 2026, MICROINTELLIGENCE (03275.HK) delayed its HK IPO on market conditions; application monies will be refunded without interest from 28 Oct.
On 23 Oct 2026, CHINA SHENHUA (01088.HK) agreed to buy the remaining 50% of Guoneng Xinjiang Coal-to-Gas for about RMB617.7m, making it a wholly-owned unit.
On 23 Oct 2026, ALPHAMAB-B (09966.HK) exercised a warrant in full to buy 4,720,365 Pathos AI shares for about US$62.5m, taking a stake of about 2%.
On 23 Oct 2026, JUNSHI BIO (01877.HK) dosed the first patient in a 282-patient Phase III trial of JS203 plus chemo in r/r DLBCL.
On 23 Oct 2026, FIRST CAP GP (01269.HK) said the High Court moved its winding-up petition hearing to 1 February 2027; scheme hearing set for 19 November 2026.
On 23 Oct 2026, GOLDWIND (02208.HK) signed a 2027 product sales framework agreement with shareholder Xinjiang Wind Power, capping annual sales at RMB 180.72mn.
